Too Old to Operate22h
A PCP’s Guide to Managing Patients After Thyroidectomy
A commentary in the Journal of Family Medicine and Primary Care advises primary care clinicians on how to manage patients ...
Hospital for Endocrine Surgery Celebrates the Best Surgeons in the World with Castle Connolly Recognition
The Hospital for Endocrine Surgery, the world's leading destination for thyroid, parathyroid, and adrenal surgery, proudly ...
Medscape1d
'Too Scared' to Deviate: When Is It Safe to De-Escalate TNBC Treatment?
One patient with TNBC describes the challenges she faced trying to de-escalate a grueling treatment regimen despite warnings ...
Endocrinology Advisor4d
Recurrent Laryngeal Nerve Injury Risk Decreases With IONM in Thyroidectomy
Recurrent laryngeal injury risk was reduced with intraoperative nerve monitoring among patients with thyroid cancer undergoing thyroidectomy.
Do mobile phones really cause cancer?
Research led by Australia’s nuclear and radiation safety agency has found no link between mobile phone use and various ...
EXEL Tops Q4 Earnings and Sales, Cabometyx Label Expansion in Focus
Exelixis beats on Q4 earnings and sales as lead drug Cabometyx maintains momentum. The company reiterates its guidance for 2025.
Telltale signs that a blemish on your arm could turn to BRAIN CANCER... after shock Teddi Mellencamp diagnosis
Real Housewives of Beverly Hills star Teddi Mellencamp, 43, was diagnosed 'multiple' brain tumors that may have been caused ...
Woman, 41, has been diagnosed with 7 different types of cancer: ‘It sucks but I’m here’
Lainie Jones has Li-Fraumeni syndrome, which makes her predisposed to having cancer. She's undergoing treatment for ...
manilatimes4d
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds ...
Exelixis’ (EXEL) “Equal Weight” Rating Reiterated at Stephens
Exelixis (NASDAQ:EXEL – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Stephens in a research note issued to investors on Wednesday,Benzinga reports.